Influenza

Identifying Nosocomial Influenza A: Whole-Genome vs Hemagglutinin/Neuraminidase Sequencing

By

Sweta Gupta Editor

Whole-genome sequencing was better at identifying nosocomial influenza A outbreak clusters than hemagglutinin (HA)/neuraminidase (NA) gene sequencing.

TransFLUas Study: Asymptomatic Influenza Transmission in Acute Health Care

By

Pulmonology Advisor Contributing Writer

A significant number of asymptomatic people shed the influenza virus.

First Clinical Development Candidate of Cidara’s Influenza Program Announced

By

Bradley van Paridon

Data supporting the selection of the antiviral conjugate CB-012 as Cidara Therapeutics Incorporated’s first clinical development candidate from the company’s influenza program.

Experimental ‘Universal’ Influenza Vaccine Being Evaluated in Healthy Volunteers

By

Cassandra Pardini, PharmD

The NIH has announced the initiation of a phase 1 clinical trial assessing the safety, tolerability, and efficacy of a “universal” influenza vaccine candidate, H1ssF_3928, in healthy adult patients.

Influenza Activity Associated With Heart Failure Hospitalization Risk

By

Pulmonology Advisor Contributing Writer

Influenza activity was linked to increased heart failure hospitalizations in 4 influenza seasons.

Efficacy of Quadrivalent Inactivated Influenza Vaccine in Young Children

By

Pulmonology Advisor Contributing Writer

In children aged 6–35 months, vaccination with 2 doses of IIV4 can protect against influenza and reduces the frequency of severe outcomes.

Antibody Response to Egg- and Cell-Grown Influenza A

By

Bradley van Paridon

Adults who received the flu vaccine in 2017 to 2018 had higher antibody titers against the egg-adapted vaccine and lower titers against circulating virus.

The CDC Estimates 2018-2019 Seasonal Influenza Vaccine Effectiveness

By

Pulmonology Advisor Contributing Writer

Influenza vaccine efficacy, between November 23, 2018 and February 2, 2019, was 47% overall and 61% for young children.